FDAnews
www.fdanews.com/articles/138604-j-amp-j-has-u-s-supply-shortage-of-cancer-drug-doxil

J&J Has U.S. Supply Shortage of Cancer Drug Doxil

July 22, 2011
Johnson & Johnson is warning doctors not to start new patients on its cancer drug Doxil due to a supply shortage — the latest in a series of shortages from various drug makers that have hamstrung healthcare providers.
MarketWatch